Literature DB >> 12524571

Pulmonary hypertension, sleep-disordered breathing, and beta blockers in heart failure patients.

Robert P Blankfield1.   

Abstract

Heart failure patients with pulmonary hypertension have a worse prognosis than heart failure patients with normal pulmonary artery pressures. Heart failure is usually considered the cause of the pulmonary hypertension when the two conditions coincide. However, there is evidence that sleep-disordered breathing may be responsible for the pulmonary hypertension in these patients, and the worsened outcomes in heart failure patients with pulmonary hypertension may be due to sleep-disordered breathing. In addition, sleep-disordered breathing may provide an explanation for the beneficial effect of beta-adrenergic antagonists in heart failure patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12524571     DOI: 10.1007/s11325-002-0181-2

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  64 in total

1.  Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy.

Authors:  S V Abramson; J F Burke; J J Kelly; J G Kitchen; M J Dougherty; D F Yih; F C McGeehin; J W Shuck; T P Phiambolis
Journal:  Ann Intern Med       Date:  1992-06-01       Impact factor: 25.391

2.  Cheyne-Stokes respiration and prognosis in congestive heart failure.

Authors:  S Andreas; G Hagenah; C Moller; G S Werner; H Kreuzer
Journal:  Am J Cardiol       Date:  1996-12-01       Impact factor: 2.778

3.  Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure.

Authors:  P A Lanfranchi; A Braghiroli; E Bosimini; G Mazzuero; R Colombo; C F Donner; P Giannuzzi
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

4.  Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics.

Authors:  M Alchanatis; G Tourkohoriti; S Kakouros; E Kosmas; S Podaras; J B Jordanoglou
Journal:  Respiration       Date:  2001       Impact factor: 3.580

5.  Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations.

Authors:  S Javaheri; T J Parker; J D Liming; W S Corbett; H Nishiyama; L Wexler; G A Roselle
Journal:  Circulation       Date:  1998-06-02       Impact factor: 29.690

6.  Pulmonary hypertension associated with long-term inhalation of "crank" methamphetamine.

Authors:  P H Schaiberger; T C Kennedy; F C Miller; J Gal; T L Petty
Journal:  Chest       Date:  1993-08       Impact factor: 9.410

7.  Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension.

Authors:  P Petitpretz; F Brenot; R Azarian; F Parent; B Rain; P Herve; G Simonneau
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

8.  Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure.

Authors:  P J Hanly; N S Zuberi-Khokhar
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

9.  Breathing pattern abnormalities and arterial oxygen desaturation during sleep in the congestive heart failure syndrome. Improvement following medical therapy.

Authors:  D S Dark; S K Pingleton; G R Kerby; J E Crabb; S B Gollub; T R Glatter; M I Dunn
Journal:  Chest       Date:  1987-06       Impact factor: 9.410

10.  The effect of sleep apnea on plasma and urinary catecholamines.

Authors:  J E Dimsdale; T Coy; M G Ziegler; S Ancoli-Israel; J Clausen
Journal:  Sleep       Date:  1995-06       Impact factor: 5.849

View more
  1 in total

1.  Sleep symptoms and clinical markers of illness in patients with heart failure.

Authors:  Karem Príncipe-Rodríguez; Kingman P Strohl; Selma Hadziefendic; Ileana L Piña
Journal:  Sleep Breath       Date:  2005-09       Impact factor: 2.816

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.